Customizing treatment to the patient: Adaptive treatment strategies

Drug and Alcohol Dependence

Volumn 88, Issue SUPPL. 2, 2007, Pages

  Murphy, Susan A ^a   Collins, L M ^b   Rush, A John ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Clinical decision support; Control engineering; Experimental design; Individualized care; Reinforcement learning; Stepped care; Structured treatment interruptions

Indexed keywords

CLINICAL DECISION MAKING; COUNSELING; DATA ANALYSIS; DRUG ABUSE; EDITORIAL; EXPERIMENTAL DESIGN; HEALTH CARE; HUMAN; INDIVIDUALIZATION; MAJOR DEPRESSION; MEDICAL LITERATURE; OFFENDER; PATIENT CARE; PRIORITY JOURNAL; REINFORCEMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 34047213941     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.02.001     Document Type: Editorial

References (20)

1. Brooner R.K., and Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Sci. Pract. Perspect. 1 (2002) 38-48
2. Collins L.M., Murphy S.A., and Bierman K.A. A conceptual framework for adaptive preventive interventions. Prev. Sci. 5 (2004) 185-196
3. Crits-Christoph P., Siqueland L., Blaine J., Frank A., Luborsky L., Onken L.S., Muenz L.R., Thase M.E., Weiss R.D., Gastfriend D.R., Woody G.E., Barber J.P., Butler S.F., Daley D., Salloum I., Bishop S., Najavits L.M., Lis J., Mercer D., Griffin M.L., Moras K., and Beck A.T. Psychosocial treatments for cocaine dependence. Arch. Gen. Psychiatry 56 (1999) 493-502
4. Lavori P.W., and Dawson R. A design for testing clinical strategies: biased individually tailored within-subject randomization. J. Roy. Stat. Soc. A 163 (2000) 29-38
5. Lavori P.W., and Dawson R. Dynamic treatment regimes: practical design considerations. Clin Trials 1 (2004) 9-20
6. Lavori P.W., Dawson R., and Rush A.J. Flexible treatment strategies in chronic disease: clinical and research implications. Biol. Psychiatry 48 (2000) 605-614
7. Lavori P.W., Rush A.J., Wisniewski S.R., Alpert J., Fava M., Kupfer D.J., Nierenberg A., Quitkin F.M., Sackeim H.A., Thase M.E., and Trivedi M. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol. Psychiatry 50 (2001) 792-801
8. Lisziewicz J., and Lori F. Structured treatment interruptions in HIV/AIDS therapy. Microbes Infect. 4 (2002) 207-214
9. McKay J.R., Lynch K.G., Shepard D.S., Ratichek S., Morrison R., Koppenhaver J., and Pettinati H.M. The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J. Consult. Clin. Psychol. 72 (2004) 967-979
10. McKay J.R. Is there a case for extended interventions for alcohol and drug use disorders?. Addiction 100 (2005) 1594-1610
11. McLellan A.T. Editorial: Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction 97 (2002) 249-252
12. McLellan A.T., Lewis D.C., O'Brien C.P., and Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000) 1689-1695
13. Miller A.L., Chiles J.A., Chiles J.K., Crismon M.L., Rush A.J., and Shon S.P. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J. Clin. Psychiatry 60 (1999) 649-657
14. Murphy S.A., and McKay J.R. Adaptive treatment strategies: an emerging approach for improving treatment effectiveness. Clin. Sci. Winter2003/Spring2004 (2004) 7-13. http://www.pantheon.yale.edu/~tat22/ http://www.pantheon.yale.edu/∼tat22/
15. Rush A.J., Rago W.V., Crismon M.L., Toprac M.G., Shon S.P., Suppes T., Miller A.L., Trivedi M.H., Swann A.C., Biggs M.M., Shores-Wilson K., Kashner T.M., Pigott T., Chiles J.A., Gilbert D.A., and Altshuler K.Z. Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. J. Clin. Psychiatry 60 (1999) 284-291
16. Rush A.J., Crismon M.L., Kashner T.M., Toprac M.G., Carmody T.J., Trivedi M.H., Suppes T., Miller A.L., Biggs M.M., Shores-Wilson K., Witte B.P., Shon S.P., Rago W.V., Altshuler K.Z., and TMAP Research Group. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J. Clin. Psychiatry 64 (2003) 357-369
17. Schneider L.S., Tariot P.N., Lyketsos C.G., Dagerman K.S., Davis K.L., Davis S., Hsiao J.K., Jeste D.V., Katz I.R., Olin J.T., Pollock B.G., Rabins P.V., Rosenheck R.A., Small G.W., Lebowitz B., and Lieberman J.A. National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE). Am. J. Geriatr. Psychiatry 9 (2001) 346-360
18. Sobell M.B., and Sobell L.C. Stepped care as a heuristic approach to the treatment of alcohol problems. J. Consult. Clin. Psychol. 68 (2000) 573-579
19. Stone R.M., Berg D.T., George S.L., Dodge R.K., Paciucci P.A., Sculman P., Lee E.J., Moore J.O., Powell B.L., and Schiffer C.A. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukaemia. New Engl. J. Med. 332 (1995) 1671-1677
20. Tummarello D., Mari D., Granziano F., Isidori P., Cetto G., Pasini F., Santo A., and Cellerino R. A randomized, controlled, phase III study of cyclophosphamide, doxorubicin and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with compete responses. Cancer 80 (1997) 2222-2229